The study evaluating the impact of cathepsin D haplodeficiency in an AD mouse (Cheng et al., 2017) focused on measurement of a few key AD-related proteins and did not rule out alterations in subtle behavioural measures or other neuropathological markers. This evidence concerns the gene CTSD and Alzheimer disease.